Financials

News Ideas Discussions Technicals Forecast Seasonals

CRNAO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Circio Holding ASA is a biotechnology company, which engages in developing novel circular RNA and immunotherapy medicines. It focuses on developing a cancer vaccine, TG01, targeting KRAS driver mutations. The company was founded on October 1, 2010 and is headquartered in Lysaker, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CRNAO does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company